İçeriğe geç

Beta Talasemi İntermedia ve Minör

Destekleyici Tedavi

Demir Kelasyonu

Iron out for nontransfused thalassemia. (yeni pencere açar)

Marks PW.

Kaynak‎: Blood 2012;120(5):928-9.

İndeks‎: PubMed 22859709

DOI‎: 10.1182/blood-2012-06-433227

https://www.ncbi.nlm.nih.gov/pubmed/22859709 (yeni pencere açar)

Iron overload in β-thalassemia intermedia: an emerging concern. (yeni pencere açar)

Musallam KM, Cappellini MD, Taher AT.

Kaynak‎: Curr Opin Hematol 2013;20(3):187-92.

İndeks‎: PubMed 23426199

DOI‎: 10.1097/MOH.0b013e32835f5a5c

https://www.ncbi.nlm.nih.gov/pubmed/23426199 (yeni pencere açar)

Gıda Takviyesi ve Diğer Destekleyici Tedaviler

Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. (yeni pencere açar)

Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE.

Kaynak‎: Blood 2012;120(7):1531-2.

İndeks‎: PubMed 22899478

DOI‎: 10.1182/blood-2012-04-422568

https://www.ncbi.nlm.nih.gov/pubmed/22899478 (yeni pencere açar)

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (yeni pencere açar)

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Kaynak‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

İndeks‎: PubMed 23449336

DOI‎: 10.1007/s12288-011-0088-9

https://www.ncbi.nlm.nih.gov/pubmed/23449336 (yeni pencere açar)

Therapeutic roles of curcumin: lessons learned from clinical trials. (yeni pencere açar)

Gupta SC, Patchva S, Aggarwal BB.

Kaynak‎: AAPS J 2013;15(1):195-218.

İndeks‎: PubMed 23143785

DOI‎: 10.1208/s12248-012-9432-8

https://www.ncbi.nlm.nih.gov/pubmed/23143785 (yeni pencere açar)

Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (yeni pencere açar)

Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S.

Kaynak‎: J Med Assoc Thai 2012;95(1):29-36.

İndeks‎: PubMed 22379738

https://www.ncbi.nlm.nih.gov/pubmed/22379738 (yeni pencere açar)

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. (yeni pencere açar)

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD.

Kaynak‎: Am J Hematol 2013;88(6):503-6.

İndeks‎: PubMed 23553596

DOI‎: 10.1002/ajh.23445

https://www.ncbi.nlm.nih.gov/pubmed/23553596 (yeni pencere açar)